Rabbit Recombinant Monoclonal FHL3 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Rat samples.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
IHC-P | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Predicted | Predicted | Predicted |
Rat | Expected | Expected | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 1/500 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 1/1000 - 1/10000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat | Dilution info 1/100 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info - | Notes - |
Recruited by SOX15 to FOXK1 promoters where it acts as a transcriptional coactivator of FOXK1.
SLIM2, FHL3, Four and a half LIM domains protein 3, FHL-3, Skeletal muscle LIM-protein 2, SLIM-2
Rabbit Recombinant Monoclonal FHL3 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human, Rat samples.
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
FHL3 also known as Four and a Half LIM Domains Protein 3 functions as a transcriptional cofactor. It weighs approximately 30 kDa. FHL3 is expressed in skeletal muscle cardiac muscle and to some degree in other tissues such as the spleen and lung. This protein consists of LIM domains known for mediating important protein-protein interactions facilitating its role in cellular activities.
The target plays an important role in transcriptional regulation and muscle development. FHL3 serves as part of transcriptional complexes and has been shown to interact with muscle-specific transcription factors. It promotes the correct expression of genes involved in the growth and maintenance of muscle tissues. Through these interactions FHL3 influences the structural and functional integrity of muscle cells.
FHL3 operates within the Wnt signaling and the insulin-like growth factor (IGF) pathways. In these pathways it interacts with several proteins such as transcription factors like MyoD and Myogenin which are critical for muscle differentiation and regeneration. These interactions help in transmitting signals that modulate gene expression patterns essential for muscle function and repair.
Mutations or aberrant expression of FHL3 associates with muscular dystrophy and certain heart conditions. In muscular dystrophy alterations in FHL3 affect muscle fiber integrity often through its interactions with other myotonic dystrophy proteins. In cardiac conditions FHL3 involvement impacts the heart muscle structure and function through its connection with proteins involved in cardiac remodeling and stress response such as the protein titin.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Blocking buffer: 5% NFDM/TBST
All lanes: Western blot - Anti-FHL3 antibody [EPR14243(B)] (ab180509) at 1/1000 dilution
Lane 1: K562 cell lysate at 20 µg
Lane 2: Rat muscle tissue lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution
Predicted band size: 31 kDa
Immunofluorescence analysis of A673 cells labeling FHL3 with ab180509 at 1/100 dilution. Secondary ab: Goat anti rabbit IgG (Alexa Fluor® 555) at 1/250 dilution. Fixative: 4% paraformaldehyde. Counter stain: Dapi
Immunohistochemical analysis of paraffin-embedded Human muscle tissue labeling FHL3 with ab180509 at 1/500 dilution. Counter stain: Hematoxylin
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Blocking buffer: 5% NFDM/TBST
All lanes: Western blot - Anti-FHL3 antibody [EPR14243(B)] (ab180509) at 1/5000 dilution
All lanes: Human skeletal muscle lysate at 20 µg
All lanes: Goat Anti-Rabbit IgG HRP (Goat Anti-Rabbit IgG H&L (HRP) ab136636) at 1/500 dilution
Predicted band size: 31 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com